Replies to post #246341 on Biotech Values

[rfj1862]

So if you had to get a lot of shots for dystonia using Botox and had to go in to the clinic once every 3 months or a new product and go in every 6 months that would not matter to you? Repeat that question for all Indications.

I think that for most of these indications patients are going to be seeing their doctor quarterly anyway. So the value proposition here is simply less shots as opposed to fewer doctor visits.

Anyway it's just my impression as an outside observer, I certainly haven't been following this closely.